Core value dossiers for medical technologies
Essential tool to support market access and marketing efforts through the lifecycle of the product
White Paper: Evidence requirements for coverage of medical technologies in the Netherlands
Get insights from MTRC White Papers to advance your understanding of five rapid HTA reports from the Netherlands
Recent news and posts
EU HTA Publication Digest: Preparing for the EU HTA Regulation: Insights from the Dutch Perspective
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest.
In a recent publication, Willemsen et al. analyzed the Dutch response to the EU Health Technology Assessment Regulation (HTAR), which took effect in January 2025. The authors detailed how the Dutch National Health Care Institute (ZIN) prepared for HTAR implementation through structured project governance and a continuous gap analysis of national HTA processes. The paper highlighted that the adoption of the Joint Clinical Assessment will require earlier scoping and national adaptation. ZIN identified key challenges in information systems, stakeholder engagement, and resource allocation, and concluded that the Netherlands is ready to integrate HTAR into national procedures and contribute to EU-level assessments.
Access the full-text article here.